CHAIR’S CORNER

For many years now, across all 50 states, healthcare providers, patient advocates, scientists, and researchers have watched with growing concern as a devastating health crisis flourished with no signs of abating: Chronic Kidney Disease (CKD) is the ninth-leading cause of death in the United States and affects more than 30 million Americans. Another 726,000 individuals…

I could write volumes on the tremendous progress we’ve made but suffice it to say that the future is brighter because of KCP’s commitment and dedication to kidney patients.

In 2017, charitable giving in the United States topped $400 billion – a mind-boggling, all-time high. Even amid a contentious political atmosphere, individual Americans, foundations, and corporations remained solidly committed to philanthropy and supporting those in need.

Through a groundbreaking public-private partnership, the U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) launched the Kidney Innovation Accelerator (KidneyX) in April to much fanfare. In order to better address the healthcare needs of 850 million people living with kidney diseases worldwide, KidneyX will kickstart the development of new medications, medical devices, digital health tools, and other products.

By Dr. Allen Nissenson, KCP Chair 30 million. That is the number of American adults who are living with chronic kidney disease (CKD) today, which – if left untreated – can progress to kidney failure. Even worse, more than half of the patients with kidney disease are not aware of their condition, leaving their disease…

By Dr. Allen Nissenson, KCP Chair Someone once said, “When you love what you do, you never ‘work’ a day in your life.” But sometimes, it’s a love affair that can drive you mad. As a physician and researcher for most of my adult life, I’ve spent hundreds upon hundreds of hours chasing objective data,…